高级检索
当前位置: 首页 > 详情页

Good coronary collateral circulation is not associated with better prognosis in patients with chronic total occlusion, regardless of treatment strategy

文献详情

资源类型:
Pubmed体系:
单位: [1]Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xuan Wu District, Beijing, China, 100050. [2]Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian City, 116011 P. R. China. [3]Department of Clinical Epidemiology and EBM, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xuan Wu District, Beijing, China, 100050
出处:
ISSN:

关键词: chronic total occlusion coronary collateral circulation percutaneous coronary intervention

摘要:
Little is known regarding the effects of coronary collateral circulation (CCC) on the prognosis of patients with chronic total occlusion (CTO) under different treatment strategies.We analyzed a total of 1124 patients who had been diagnosed with CTO and divided them into groups with good CCC (grade 2 to 3, n = 539) or poor CCC (grade 0 to 1, n = 531). The primary outcome was cardiac death during follow-up; the secondary outcome was major adverse cardiovascular events (MACEs). We also performed subgroup analyses in groups with and without CTO revascularization (CTO-R and CTO-NR, respectively), and sensitivity analyses excluding patients who received failed CTO-PCI, to further investigate the effect of CCC.During a median follow-up duration of 23 months, we did not detect any significant differences between the good CCC group and the poor CCC group in terms of cardiac death (4.2% vs 4.1%; adjusted hazard ratio [HR], 1.01; 95% confidence interval [CI], 0.56-1.83; p = 0.970) and MACEs (23.6% vs 23.2%; adjusted HR, 1.07; 95% CI, 0.84-1.37; p = 0.590). Subgroup analyses according to CTO revascularization showed similar results. In addition, we observed no differences in sensitivity analyses when patients who received failed CTO-PCI were excluded.Good CCC was not associated with a lower risk of cardiac death or MACEs among patients with CTO, regardless of whether the patients received CTO revascularization treatment.Copyright © 2022 Hellenic Society of Cardiology. Published by Elsevier B.V. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 心脏和心血管系统
JCR分区:
出版当年[2020]版:
最新[2023]版:
Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xuan Wu District, Beijing, China, 100050.
共同第一作者:
通讯作者:
通讯机构: [1]Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xuan Wu District, Beijing, China, 100050. [2]Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian City, 116011 P. R. China. [*1]Internal Medicine, Cardiac Center/ Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Beijing City, P.R. China 100053
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)